Vaccinia Virus and Dendritic (Langerhans) Cells: Need for Elucidation of the Role of Dendritic Cells in Vaccination

  • Yechiel Becker
Part of the Developments in Medical Virology book series (DIMV, volume 7)


In the review on smallpox by Behbahani (1) it is indicated that Edward Jenner used materials from individuals infected with cowpox or horsepox (grease) for immunization. The live vaccines subsequently used were produced from four basic strains: a) The Lister Institute or Elstree strain in the United Kingdom that originated from a Prussian soldier with smallpox during the 1870 Franco-Prussian war and was introduced into Britian from Cologne as calf lymph in 1907, b) the Wyeth or the New York Board strain in the United States of America that was started in 1876 from an unidentified vaccine imported from Britain in the 1850s, c) the EMG 3 strain in the USSR which was derived from a commercial vaccine of unknown origin from Ecuador, and d) a vaccine strain strain designated Tian Tan strain that is being used in China.


Dendritic Cell Vaccinia Virus Recombinant Vaccinia Virus Smallpox Vaccination Smallpox Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Behbehani A.M., Microbiol. Rev. 47:455–509, 1983.PubMedGoogle Scholar
  2. 2.
    Baxby D., Ashton D.G., Jones D.M. and Thomsett L.R., J. Hyg. Camb. 89:365–372, 1982.PubMedCrossRefGoogle Scholar
  3. 3.
    Esposito J.J. and Knight J.C. Virology 143:230–251, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    Hou Y.T., Yang, Y.K. and Hu Y.W. J. Gen. Virol. 66:1819–1823, 1985.PubMedCrossRefGoogle Scholar
  5. 5.
    Fulginiti V.A. and Feingold M. Am. J. Dis. Child. 138:321–322, 1986.Google Scholar
  6. 6.
    Rich J.D., Shesol B.F. and Horne D.W. J Clin. Pathol. 33:134–135, 1980.PubMedCrossRefGoogle Scholar
  7. 7.
    Slater D.N., Parsons M.A. and Fussey I.V. Brit. J. Dermatol. 105:215–217, 1981.CrossRefGoogle Scholar
  8. 8.
    Nagao S. and Inaba S. Arch. Dermatol. Res. 256:23–31, 1976.PubMedCrossRefGoogle Scholar
  9. 9.
    Smith G.L., Mackett M. and Moss B. Nature 302:490–495, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Smith G.L., Murphy B.R. and Moss B. Proc. Natl. Acad. Sci. USA 80:5364–5368, 1982.Google Scholar
  11. 11.
    Hu S-L, Kosowski S.E. and Dalrymple J.M. Nature 320:537–540, 1986.PubMedCrossRefGoogle Scholar
  12. 12.
    Esposito J., Breching K., Baer G. and Moss B. Virus Genes 1:1–21, 1987.Google Scholar
  13. 13.
    Panicali D. and David S.N. Proc. Natl. Acad. Sci. USA, 80:5364–5368, 1983.PubMedCrossRefGoogle Scholar
  14. 14.
    Becker Y. and Sprecher E. Arch. Virol. 107:307–313, 1989.PubMedCrossRefGoogle Scholar
  15. 15.
    Becker Y. Virus Genes 1:117–120, 1987.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Yechiel Becker
    • 1
  1. 1.Department of Molecular Virology, Faculty of MedicineHebrew UniversityJerusalemIsrael

Personalised recommendations